RT Book, Section
A1 Zeigler, Michelle
A1 Hall, Anna
A1 Endiakov, Alexandre
A1 Dewar, Marvin A.
A2 Whalen, Karen
A2 Hardin, Heather C.
SR Print(0)
ID 1150196365
T1 Perspectives: Patient, Pharmacist, and Physician Views of MTM
T2 Medication Therapy Management: A Comprehensive Approach, 2e
YR 2018
FD 2018
PB McGraw-Hill Education
PP New York, NY
SN 9781260108453
LK accesspharmacy.mhmedical.com/content.aspx?aid=1150196365
RD 2022/07/01
AB KEY  POINTSAchieving  high  patient  participation  rates  in  medication  therapy  management  (MTM)  services  for  Medicare  Part  D  plans  has  been  challenging  since  the  inception  of  MTM.Patient  barriers  to  participating  in  MTM  services  include  lack  of  familiarity  with  what  the  services  include  and  benefits  of  participation.Health  plans  are  measured  on  MTM  comprehensive  medication  review  (CMR)  completion  rate,  so  overcoming  barriers  to  MTM  provision  is  essential  to  improve  patient  participation.Pharmacists  often  face  barriers  to  providing  MTM  services,  including  compensation,  time,  staffing  issues,  and  collaboration.Key  stressors  in  the  current  physician  practice  environment  include  dealing  with  increasing  administrative  burdens,  integrating  electronic  health  records  into  practice  workflows,  and  downward  pressures  on  physician  income.Payer  value-based  purchasing  programs  increasingly  score  physicians  on  clinical  and  efficiency  metrics  and  tie  reimbursement  to  those  metrics.Survey  data  indicate  that  physicians  have  an  incomplete  understanding  of  MTM  programs.Physicians  respond  most  favorably  to  MTM  services  such  as  general  patient  medication  education,  identifying  prescribing  errors,  assisting  patients  with  obtaining  refills,  developing  accurate  medication  lists,  working  to  increase  patient  adherence,  and  detecting  medication  adverse  effects.  Physicians  express  concerns  about  MTM  programs  creating  ambiguity  about  professional  roles,  imposing  new  and  additional  administrative  or  time  burdens  on  physicians,  and  the  sufficiency  of  pharmacist  training  for  disease  state  education  and  specific  medication  recommendations.  More  high  quality  evidence  is  needed  on  the  impact  of  MTM  programs  on  ultimate  health  outcomes  and  cost  reduction.Key  opportunities  for  pharmacists  and  physicians  to  work  together  in  the  MTM  arena  include  supporting  more  research  into  MTM  effectiveness,  promoting  innovations  that  integrate  MTM  services  into  electronic  health  records  (EHRs),  and  establishing  adequate  reimbursement  for  MTM.